ABA Health Law Section

The brochure for the 2024 Healthcare Delivery & Innovation conference is available now! Register by COB this Wednesday (6/19) for 15% off using code HDIFlash at checkout!

https://events.americanbar.org/event/3ac5110c-289c-4fb7-94d7-d3bfb070bcfc/summary

The May 2024 Issue of eSource is out now!

Health eSource - May 2024 In the May 2024 edition of eSource: The Future of the Pharmaceutical Industry’s Hold on Intellectual Property Rights | Top 3 Clinical Issues Trending in Healthcare Fraud and Abuse Litigation

We can't believe it's already been 3 weeks since ! Thank you to everyone who helped make this conference unforgettable. We can't wait to see you all in Long Beach next year!

Healthcare Transactions Oversight, Next Generation Conduct Investigations and More! Register now for the 2024 Antitrust in Healthcare Conference!
https://web.cvent.com/event/0586d066-89c3-4dcf-9205-1740bdf740e8/summary

New Episode of Voices in Health Law out now!

In honor of National Healthcare Decisions Day earlier this week, join Stephanie Dorvil and Nathan Kottkamp for a great discussion on "Advance Directives – The Basics and Why Everyone Needs One" This episode is part of a two-part series on Advance Directives. Part 2 will be out later this month.

Significant private equity investment in healthcare has resulted in increased regulatory scrutiny and enforcement… In March eSource, authors from Venable LLP discuss the steps private equity firms can take to mitigate their FCA exposure.

Enforcement of Private Equity Investment in Healthcare Significant private equity investment in the healthcare space has resulted in increased regulatory scrutiny and enforcement. From False Claims Act (FCA) settlements to bipartisan congressional inquiries, concerns by the Office of Inspector General of

In the March issue of ABA Health eSource, a team from Nichols Liu LLP discusses the False Claims Act cases that they believe to be the most significant of 2023, including two that were decided by the Supreme Court.

Top False Claims Act Developments of 2023 The Department of Justice (DOJ) recently reported approximately $2.7 billion in False Claims Act (FCA) recoveries in fiscal year 2023. The DOJ report on FCA settlements and recoveries wasn’t issued until the end of February—the latest release date

As remote patient monitoring (RPM) has grown and changed, so have the RPM rules and regs. In the March ABA Health eSource, authors from Robinson Cole discuss what providers need to know to avoid compliance issues when providing RPM.

Remote Patient Monitoring Enforcement Initiatives In recent years, there has been a significant increase in the use of digital technologies and innovative solutions in healthcare, including the increased use of remote patient monitoring (RPM) services. Telehealth and other digital therapies

Last chance to register! is only one week away! We can't wait to see you in New Orleans!
https://buff.ly/484HsVo

The March 2024 edition of eSource is out now!

Health eSource - March 2024 In the March 2024 edition of eSource: Remote Patient Monitoring Enforcement Initiatives | Top False Claims Act Developments of 2023 | Enforcement of Private Equity Investment in Healthcare: Past, Present, and Future Trends

The official brochure for is available now! Register by COB Friday (3/22) using code ATHCFLASH for 15% off!
https://buff.ly/3PxRiJ4

In this week’s , host Andrew J. Demetriou discusses the bytes on the latest in the Change Healthcare Breach and 340B both submitted by HLbytes editor David Ermer. For more on these story and others like it, go to buff.ly/3HWcNiz and check your inbox every Friday for the next edition of HLbytes.

https://buff.ly/4crVlk2

Join Mysty Blagg, Alan Horowitz and Dr. Karl Steinberg tomorrow (3/19) for this free webinar. Register now!
https://buff.ly/3V1hMpP

New episode of Voices in Health Law: "Data Strategy and Changing Privacy Regulations" with Jeremy Shapiro-Barr and Shannon Hartsfield
https://buff.ly/3IbwkM1

New pharmacy business models and increased transparency may shake up the industry, but will they lower costs for patients? Learn more about these changes in this eSource article by Hayley White Coley of Norton Rose Fulbright.

More Transparency, But Will It Lower Drug Prices? On December 5, 2023, CVS Health, which owns the largest drugstore chain in the United States, announced its plan to overhaul how it reimburses its 9,500 pharmacies for prescription drugs. Under the new model, called CVS CostVantage, CVS’s pharmacies

Reminder: Submit your proposals for
https://buff.ly/4bOg6WI

Join Richard Cheng and Lisa Gora for "The World of Emerging Therapies and Alternative Substances in Healthcare" only at
https://buff.ly/484HsVo

In this week’s , host Ramana Rameswaran discusses HHS and CMS Responses to Change Healthcare Outage and Cross Government Inquiry on Private Equity submitted by HLbytes editor David Ermer in last week's Washington Roundup. For more on this story and others like it, check your inbox every Friday for the next edition of HLbytes.
https://buff.ly/3TvisCG

Join Mysty Blagg, Alan Horowitz and Dr. Karl Steinberg next Tuesday (3/19) for this free webinar. Register now!
https://buff.ly/3V1hMpP

Tomorrow (3/13) join Jim Daniel, Pam D'Apuzzo and Lourdes Martinez for this free webinar!
https://buff.ly/3uZpyWA

AI offers potential for great innovation in healthcare, but it also presents some real risks. In this eSource article, a team from McGuire Woods discusses some of the risks presented by this new technology in healthcare.

The Effects of Artificial Intelligence on Healthcare Delivery In 2023, artificial intelligence and machine learning (AI/ML) emerged as both a potential boon and a concern in healthcare as stakeholders and the Biden Administration worked to balance rapid advancement with the need for security, transparency, and

The various exceptions within state abortion bans have created confusion for providers and organizations, and health harm to patients. This eSource article by authors from the Center for Reproductive Rights discusses the ramifications of these inconsistencies.

Navigating the Maze The U.S. Supreme Court’s decision in Dobbs took away the federal fundamental right to abortion, paving the way for states to ban or severely restrict access. Currently, 14 states are enforcing near-total abortion bans, which has created chaos and

HHS has recently recommended that the DEA reschedule cannabis as a less-dangerous drug. What are the legal, finance, tax, and medical/scientific research implications? Learn more in this article from the Feb issue of ABA Health Lawyer.

The Rescheduling of Cannabis In August 2023, the U.S. Department of Health and Human Services (HHS) recommended to the U.S. Drug Enforcement Agency (DEA) that ma*****na, also known as cannabis, should be rescheduled to Schedule III of the Controlled Substances Act (CSA).

New Episode of Voices in Health Law:
"A Practical Guide to Reimbursement in Managed Care" Join Jeff Wurzburg as he talks to JoAnna Younts about her new book!
https://buff.ly/3IbwkM1

Next Wednesday (3/13) join Jim Daniel, Pam D'Apuzzo and Lourdes Martinez for this free webinar!
https://buff.ly/3uZpyWA

Only a few days left to book your room at the JW Marriott for ! Space is limited so don't wait!
https://buff.ly/484HsVo

In this week’s , host Jeff Wurzburg discusses the byte entitled “Ongoing Change Healthcare Breach” submitted by David Ermer and more. For more on this story and others like it, go to buff.ly/3HWcNiz and check your inbox every Friday for the next edition of HLbytes.
https://buff.ly/3InI8L3

Calling All Young Lawyers!
Join Kenneth White and Anthony Box tomorrow (3/6) for the latest session of our "What is Health Law?" series!
https://buff.ly/3TfJJcj